Asthma plus migraine in childhood and adolescence: Prophylactic benefits with leukotriene receptor antagonist

Headache

Volumn 42, Issue 10, 2002, Pages 1044-1047

  De Souza Carvalho, Deusvenir ^a,b   Dadalti Fragoso, Yara ^a   Santos Coelho, Fernando Morgadinho ^a   Machado Pereira, Mariana ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Asthma; Comorbidity; Leukotriene; Migraine; Migraine prevention and control; Montelukast

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MALE; MIGRAINE; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; SCHOOL CHILD;

ACETATES; ADOLESCENT; ASTHMA; CHILD; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIGRAINE DISORDERS; PROSPECTIVE STUDIES; QUINOLINES; TREATMENT OUTCOME;

EID: 0036863302     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.02236.x     Document Type: Article

References (12)

1. Moskovitz MA. The neurobiology of vascular head pain. Ann Neurol. 1984;16:157-168.
2. Selmaj K, de Belleroche J, Das I, Rose FC. Leukotriene B4 generation by polymorphonuclear leukocytes: Possible involvement in the pathogenesis of headache. Headache. 1986;26:460-464.
3. Gazzaniga PP, Ferroni P, Lenti L, et al. Identification of blood leukotrienes in classical migraine. Headache. 1987;27:211-215.
4. LaMancusa R, Pulcinelli FM, Ferroni P, et al. Blood leukotrienes in headache: Correlation with platelet activity. Headache. 1991;31:409-414.
5. American Academy of Neurology. Practice Guidelines. AAN Headache Guidelines: Multispecialty Consensus on Diagnosis and Treatment of Headache. [cited 2001 Nov 19] Available from URL. www.aan.com
6. National Heart, Lung and Blood Institute: Expert Panel Report 2. Guidelines in the diagnosis and management of asthma. Natl Inst Health. 1997;97-4051:1-153.
7. International Headache Society. Headache classification committee, classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl. 7):1-96.
8. Winner P, Martinez W, Mate L, et al. Classification of pediatric migraine: Proposed revisions to the IHS criteria. Headache. 1995;35:407-410.
9. Winner P, Wasiewski W, Gladstein J, et al. Multicenter prospective evaluation of proposed pediatric migraine revisions to the IHS criteria. Headache. 1997;37:545-548.
10. Sheftell F, Rapoport A, Weeks R, et al. Montelukast in the prophylaxis of migraine: A potent role for leukotriene modifiers. Headache. 2000;40:158-163.
11. Freitag FG, Diamond S, Diamond ML, Urban G. Preventive treatment of migraine headache with rofecoxib and montelukast (abstract of poster presentation). Cephalalgia. 2001;21:375.
12. Pearlman EM, Fisher S. Preventive treatment for childhood and adolescent headache: Role of once-daily montelukast sodium (abstract of poster presentation). Cephalalgia. 2001;21:461.